Highlights Avid Bioservices, Inc.

Equities

CDMO

US05368M1062

Real-time Estimate Cboe BZX Other stock markets 16:54:55 08/05/2024 BST			5-day change	1st Jan Change
8.6 ^USD	-1.83%		+13.43%	+33.85%

04-30	RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating	MT
04-29	Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avid Bioservices, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	04-24	CI
North American Morning Briefing : Stock Futures -2-	04-19	DJ
North American Morning Briefing : Stocks Struggle After New Records	03-22	DJ
Avid Bioservices Receives Nasdaq Noncompliance Notice	03-20	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Buoyed by Powell's Comments	03-07	MT
Avid Bioservices Shares Slide After Pricing Private Placement of Convertible Notes	03-07	DJ
Avid Bioservices Preliminary Fiscal Q3 Revenue Falls 11%; $160 Million Private Placement of Notes Set; Shares Slump	03-06	MT
Avid Bioservices, Inc. Maintains Revenue Guidance for Full Fiscal Year 2024	03-06	CI
Avid Bioservices Faces Uphill Battle as Overall Demand Environment Poses Challenges, RBC Says	12-08	MT
November Payrolls Post Bigger Gain Than Expected as Exchange-Traded Funds, Equity Futures Slide Pre-Bell	12-08	MT
Avid Bioservices Fiscal Q2 Loss Widens, Revenue Falls; Cuts Fiscal 2024 Sales Outlook; Shares Plunge Premarket	12-08	MT
Avid Bioservices Fiscal Q2 Loss Widens, Revenue Falls; Fiscal 2024 Revenue Outlook Cut; Shares Slump After Hours	12-07	MT
Avid Bioservices, Inc. Revises Revenue Guidance for the Full Fiscal Year 2024	12-07	CI
Avid Bioservices, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	12-07	CI
Avid Bioservices Partners with California Institute for Regenerative Medicine to Provide CDMO Services for Cell and Gene Therapy Programs	11-08	CI
Avid Bioservices Completes Construction of New Cell, Gene Therapy Facility	17/10/23	MT
Avid Bioservices Swings to Loss in Fiscal Q1 While Revenue Rises	07/09/23	MT
Avid Bioservices, Inc. Reiterates Revenue Guidance for Full Fiscal Year 2024	07/09/23	CI
Avid Bioservices, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	07/09/23	CI
Avid Bioservices Issues Downbeat Fiscal 2024 Revenue Forecast Following Mixed Fourth-Quarter	22/06/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Avid Bioservices, Inc.

Equities

CDMO

US05368M1062

Highlights

Filters